|
Market Closed -
Other stock markets
|
After hours 05:26:24 am | |||
| 675.19 USD | +0.45% |
|
681.40 | +0.92% |
| 21/07 | Cantor Fitzgerald Adjusts Price Target on Regeneron Pharmaceuticals to $750 From $785 | MT |
| 21/07 | Guggenheim Adjusts PT on Regeneron Pharmaceuticals to $1,000 From $995, Maintains Buy Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Biopharmaceuticals | +0.45% | +2.91% | -12.53% | +23.77% | +15.67% | 6.84TCr |  |  |  |
- Stock Market
- Stocks
- REGN Stock
- Charts Regeneron Pharmaceuticals, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition